These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6761860

  • 1. Captopril in treatment-resistant essential and renal hypertension.
    Aurell M, Delin K, Herlitz H.
    Scand J Urol Nephrol; 1982; 16(3):243-9. PubMed ID: 6761860
    [Abstract] [Full Text] [Related]

  • 2. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA, Drayer JI, Priest RT, Chen TC.
    Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
    [Abstract] [Full Text] [Related]

  • 3. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E, Rosenthal T, Stern N, Knecht A, Yaron A.
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [Abstract] [Full Text] [Related]

  • 4. Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.
    Havelka J, Vetter H, Studer A, Greminger P, Lüscher T, Wollnik S, Siegenthaler W, Vetter W.
    Am J Cardiol; 1982 Apr 21; 49(6):1467-74. PubMed ID: 6280477
    [No Abstract] [Full Text] [Related]

  • 5. The antihypertensive effect of captopril in severe essential, renovascular, renal and transplant renovascular hypertension.
    Schwietzer G, Oelkers W.
    Klin Wochenschr; 1982 Aug 16; 60(16):839-46. PubMed ID: 6752559
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension.
    Aldigier JC, Plouin PF, Guyene TT, Thibonnier M, Corvol P, Menard J.
    Am J Cardiol; 1982 Apr 21; 49(6):1447-52. PubMed ID: 7041584
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antihypertensive effects of captopril and saralasin in essential and renal hypertension.
    Konrads A, Meurer KA, Hummerich W, Wambach G, Kindler J, Feltkamp H, Helber A.
    Am J Cardiol; 1982 Apr 21; 49(6):1558-60. PubMed ID: 7041597
    [Abstract] [Full Text] [Related]

  • 11. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF, Russell GI, Swales JD, Thurston H.
    J Lab Clin Med; 1981 Aug 21; 98(2):302-10. PubMed ID: 7019368
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
    Wenting GJ, de Bruyn JH, Man in't Veld AJ, Woittiez AJ, Derkx FH, Schalekamp MA.
    Am J Cardiol; 1982 Apr 21; 49(6):1453-9. PubMed ID: 6803562
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Captopril treatment in hypertensive dialysis patients.
    Aurell M, Delin K, Herlitz H, Mulec H.
    Scand J Urol Nephrol; 1982 Apr 21; 16(3):251-6. PubMed ID: 6761861
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.